FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Autologous topics
Autologous
Stem Cells
Differentiation
Fibroblast
Cell Therapy
Transplant
Cell Differentiation
Tissue Engineering
Myeloid Leukemia
Gene Expression
Acute Myeloid Leukemia
Complication
Umbilical Cord
Premature Birth
Premature Infant

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Autologous patents



      
           
This page is updated frequently with new Autologous-related patent applications. Subscribe to the Autologous RSS feed to automatically get the update: related Autologous RSS feeds. RSS updates for this page: Autologous RSS RSS


Date/App# patent app List of recent Autologous-related patents
10/09/14
20140302605
 Method of obtaining a population of cells patent thumbnailMethod of obtaining a population of cells
A method of obtaining stromal progenitor cells (spc) from subcutaneous adipose tissue by incubation of a very small volume of the subcutaneous adipose tissue in an enzyme solution produces spc that are usable in medical applications based on autologous spc even on individuals having a body mass index lower than 18.5.. .
10/09/14
20140302052
 Combination therapy to enhance nk cell mediated cytotoxicity patent thumbnailCombination therapy to enhance nk cell mediated cytotoxicity
The function of natural killer (nk) cells is regulated by inhibitory and activating signals delivered by cell surface receptors, 1-7f9 is a fully human monoclonal antibody (mab) directed against kir2dl1 and k1r2dl2/3 receptors that blocks its interaction with its hla-c ligands breaking nk cell tolerance to autologous tumor ceils. Lεnalidomide has been shown to increase nk cell cytotoxicity in vitro.
10/09/14
20140301987
 Structure for tissue regeneration and a production method therefor patent thumbnailStructure for tissue regeneration and a production method therefor
The present invention relates to a structure for tissue regeneration and to a production method therefor. The structure for tissue regeneration according to the present invention allows autologous tissue to be used, makes stable transplantation possible and can be produced without additional materials such as biopolymers.
10/09/14
20140301985
 Method of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree patent thumbnailMethod of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree
A method of repairing diseased or dysfunctional pancreas or liver is provided. The method involves preparation of a suspension of stem cells and/or progenitor cells such as biliary tree stem cells, hepatic stem cells, pancreatic stem cells or their descendants, committed progenitor cells, from healthy tissue of the patient or of the biliary tree of a non-autologous donor and engrafting the cells into the wall of bile ducts near to the organ to be treated.
09/25/14
20140288661
 Bone tissue engineering by ex vivo stem cells ongrowth into three-dimensional trabecular metal patent thumbnailBone tissue engineering by ex vivo stem cells ongrowth into three-dimensional trabecular metal
Adult autologous stem cells cultured on a porous, three-dimensional tissue scaffold-implant for bone regeneration by the use of a hyaluronan and/or dexamethasone to accelerate bone healing alone or in combination with recombinant growth factors or transfected osteogenic genes. The scaffold-implant may be machined into a custom-shaped three-dimensional cell culture system for support of cell growth, reservoir for peptides, recombinant growth factors, cytokines and antineoplastic drugs in the presence of a hyaluronan and/or dexamethasone alone or in combination with growth factors or transfected osteogenic genes, to be assembled ex vivo in a tissue incubator for implantation into bone tissue..
09/25/14
20140287020
 Surgical device for skin therapy or testing patent thumbnailSurgical device for skin therapy or testing
A device, and method of making the device, capable of therapeutic treatment and/or for in vitro testing of human skin. The device may be used on skin wounds for burned, injured, or diseased skin, and provides structures and functions as in normal uninjured skin, such as barrier function, which is a definitive property of normal skin.
09/25/14
20140286870
 Rapid infusion of autologous bone marrow derived stem cells patent thumbnailRapid infusion of autologous bone marrow derived stem cells
The present invention relates to a method and composition for the aspiration, processing, testing and infusion of bone marrow derived stem cells, as an adjuvant treatment in cardiovascular disorders. More specifically, the invention provides for the methods and compositions for the aspiration, analysis, processing, infusate preparation and infusion of bone-marrow derived stem cells, particularly in a rapid point-of-care environment, wherein a centrifugal fractionation and optically monitored separation of the bone marrow yield desired cellular product in the desired concentration and viscosity..
09/25/14
20140286869
 Rapid infusion of autologous bone marrow derived stem cells patent thumbnailRapid infusion of autologous bone marrow derived stem cells
The present invention relates to a method and composition for the aspiration, processing, testing and infusion of bone marrow derived stem cells, as an adjuvant treatment in cardiovascular disorders. More specifically, the invention provides for the methods and compositions for the aspiration, analysis, processing, infusate preparation and infusion of bone-marrow derived stem cells, particularly in a rapid point-of-care environment, wherein a centrifugal fractionation and optically monitored separation of the bone marrow yield desired cellular product in the desired concentration and viscosity..
09/18/14
20140274788
 Leukemia stem cell markers patent thumbnailLeukemia stem cell markers
The invention provides a test method for predicting the initial onset or a recurrence of acute myeloid leukemia (aml) comprising (1) measuring the expression level of human leukemic stem cell (lsc) marker genes in a biological sample collected from a subject for a transcription product or translation product of the gene as an analyte and (2) comparing the expression level with a reference value; an lsc-targeting therapeutic agent for aml capable of suppressing the expression of a gene selected from among lsc marker genes or a substance capable of suppressing the activity of a translation product of the gene; a method for producing a sample containing hematopoietic cells for autologous transplantation or allogeneic transplantation for aml patients, comprising obtaining an lsc-purged sample with at least 1 kind of lsc marker as an index; and a method of preventing or treating aml.. .
09/18/14
20140271587
 Treatment of inflammatory respiratory disease using biological solutions patent thumbnailTreatment of inflammatory respiratory disease using biological solutions
Methods and therapeutic compositions for treating respiratory diseases, such as chronic obstructive pulmonary disease (copd) and devices for administering the therapeutic compositions. Methods for treatment include producing a protein solution, producing a concentrated bone marrow aspirate (cbma), optionally combining the protein solution and cbma to form an therapeutic composition, and optionally saturating the autologous therapeutic composition with hydrogen gas, and administering the therapeutic composition to a subject in need thereof.
09/18/14
20140271582
Cd123-specific chimeric antigen receptor redirected t cells and methods of their use
A family of chimeric antigen receptors (cars) containing a cd123 specific scfv was developed to target different epitopes on cd123. In some embodiments, such a cd123 chimeric antigen receptor (cd123car) gene includes an anti-cd123 scfv region fused in frame to a modified igg4 hinge region comprising an s228p substitution, an l235e substitution, and optionally an n297q substitution; a costimulatory signaling domain; and a t cell receptor (tcr) zeta chain signaling domain.
09/18/14
20140271356
Cpb system with dual function blood reservoir
The venous reservoir is omitted from an extracorporeal blood circuit system by substituting a blood reservoir in parallel with the arterial pump. The reservoir has an inlet connected to the outlet of the pump and an outlet connected to the inlet of the pump.
09/11/14
20140257481
Breast reconstruction device and methods
A novel human breast implant and method for using the same comprising a bioabsorbable implant into which native, autologous vascularized tissue and autologous fat is placed and propagated within a patient's chest as a breast implant.. .
09/04/14
20140249071
Enhanced anabolic cytokine production and delivery system
Techniques and devices for removing (filtering out) unwanted/inhibitory components (for example, products, byproducts and/or cell output such as inhibitory catabolic proteins) from a composition (for example, autologous fluid or serum) containing such unwanted/inhibitory components. The devices include at least one construct designed to contain a composition (for example, autologous fluid or serum) containing inhibitory/unwanted components (products, byproducts and/or output of cells such as inhibitory catabolic proteins).
09/04/14
20140248331
Polyhydroxyalkanoate medical textiles and fibers
Absorbable polyester fibers, braids, and surgical meshes with prolonged strength retention have been developed. These devices are preferably derived from biocompatible copolymers or homopolymers of 4-hydroxybutyrate.
09/04/14
20140246802
Polyhydroxyalkanoate medical textiles and fibers
Absorbable polyester fibers, braids, and surgical meshes with prolonged strength retention have been developed. These devices are preferably derived from biocompatible copolymers or nomopolymers of 4-hydroxybutyrate.
08/28/14
20140242125
Muscle tissue regeneration using muscle fiber fragments
The invention is directed to methods and compositions for obtaining uniform sized muscle fiber fragments for transplantation. These muscle fiber fragments are able to reconstitute into long fibers that are oriented along native muscle.
08/28/14
20140242118
Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy
In one aspect, the present invention provides a method for treating cancer comprising tumor cell vaccination in combination with hematopoietic and immune cell transplantation. In some embodiments, the method involves autologous tumor cell vaccination prior to autologous hematopoietic and immune cell transplantation.
08/14/14
20140228812
Method for reducing tumors and transforming cancer cells
This invention is related to a phenol-quinone therapy that shrinks tumors and transforms cancer cells. The therapy include four phases.
08/14/14
20140227339
Regenerative tissue grafts and methods of making same
A graft containing a scaffold that includes a matrix in which are positioned mesenchymal progenitor cells (mpcs) has the capacity to substantially improve wound healing, including wounds resulting from injury to nerve, bone and vascular tissue. Mpcs can be harvested from debrided muscle tissue following orthopaedic trauma.
08/07/14
20140220682
Isolation, expansion and use of autologous pluripotent stem cells
The present invention relates to methods of isolating and culturing autologous pluripotent stem (aps) cells. The present invention also provides isolated aps cells, populations of aps cells and cultures of aps cells.
08/07/14
20140219980
Treatment for mitochondrial neurogastrointestinal encephalomyopathy (mngie)
The invention provides a method of treating mitochondrial neurogastrointestinal encephalomyopathy (mngie) in a patient, comprising administering to the patient autologous erythrocytes that contain thymidine phosphorylase and are free of animal proteins other than proteins derived from the patient. The erythrocytes generally contain a low amount of endotoxin..
07/31/14
20140212391
Vaginal laxity therapy utilizing cell-based bulking compositions
The invention provides methods for the treatment of vaginal laxity which include delivering a cell-containing composition to the vagina. The composition can include fat tissue to provide a bulking effect to reduce the size of the vaginal opening.
07/24/14
20140207105
Methods for effectively and rapidly desensitizing allergic patients
Methods and compositions for delivering antigens to the lymphatic system in doses that desensitize patients to future exposure to antigens have been developed. Rapid desensitization is achieved by introducing small quantities of antigen into the lymphatic system.
07/24/14
20140205676
Method of tissue repair using a composite material
A composite biocompatible hydrogel material includes a porous polymer matrix, the polymer matrix including a plurality of pores and providing a young's modulus of at least 10 gpa. A calcium comprising salt is disposed in at least some of the pores.
07/24/14
20140205514
Blood separating vessel for extracting autologous platelets, and apparatus for extracting autologous platelets
Provided is a blood separating vessel for extracting autologous platelets, and an apparatus for extracting autologous platelets. The blood separating vessel for extracting autologous platelets comprises: a main body defining an internal space divided into an upper fluid chamber and a lower fluid chamber; an upper cover disposed to seal an upper portion of the upper fluid chamber; a lower cover disposed to seal a lower portion of the lower fluid chamber, the lower cover being coupled such that an outer peripheral surface of the lower cover is elevatable in a state of being in close contact along an inner peripheral surface of the lower fluid chamber by an external force applied upward; and a fluid collection part dividing the internal space into the upper fluid chamber and the lower fluid chamber and including a fluid passage protruding upward to communicate the upper fluid chamber with the lower fluid chamber..
07/10/14
20140194881
Drill, drill cover, and surgical instrument for collecting autologous bone employing same
A drill and drill cover and autogenous bone collector using the same are provided. The autogenous bone collector comprises s shaft unit connected to a driving device and a cutting unit which revolves and collects bone paticles of a patient.
06/26/14
20140178346
Cellular compositions for tissue engineering
Cell compositions for tissue engineering are provided which contain a population of autologous, minimally passaged dermal fibroblasts in combination with a tissue engineering matrix or scaffold, or material forming a matrix or scaffold. In one embodiment, the population of fibroblasts is genetically engineered to secrete a therapeutic protein in an amount effective to induce tissue growth or tissue repair when the cell composition is transplanted into a subject in need thereof.
06/19/14
20140170176
Treatment method for relapsing-remitting multiple sclerosis
Disclosed is a method for treating relapsing-remitting multiple sclerosis in a patient by administering to the patient autologous, ex vivo-expanded cd4+cd25+foxp3+cd127low t reg cells when the patient is in remission. Also disclosed is a method of inhibiting the activity of autoimmune, autologous cytotoxic t and b cells in a patient suffering from relapsing-remitting multiple sclerosis, comprising administering a therapeutically effective amount of autologous cd4+cd25+foxp3+cd127low t reg cells to the patient..
06/12/14
20140162355
Formulations containing and kit for using adipose-derived stem cells and use thereof
Methods and kits for producing cellular fractions enriched in adipose derived stem cells. Methods are provided where adipose tissue obtained from liposuction is enzymatically treated using a solution containing collagenase and divalent cations prior to the application of traditional methods of stromal-vascular fraction isolation.
05/22/14
20140142718
Flexible tissue matrix and methods for joint repair
A synthetic, flexible tissue matrix and methods for repairing hyaline cartilage defects in a joint using the flexible tissue matrix are described. The flexible tissue matrix includes a high molecular weight polycaprolactone polymer entangled with a polysaccharide such as hyaluronic acid.
05/22/14
20140141047
Selection of platelet rich plasma components via mineral binding
Mineral coated devices and methods for delivering an autologous biological molecule using the mineral coated devices are disclosed. The mineral coated devices allow for the isolation and delivery of a biological molecule obtained from the same subject to avoid the safety concerns of current biological therapies obtained by recombinant methods and purification from animal sources.
05/15/14
20140135925
Breast reconstruction device and methods
A novel human breast implant and method for using the same comprising a bioabsorbable implant into which native, autologous vascularized tissue and autologous fat is placed and propagated within a patient's chest as a breast implant.. .
05/08/14
20140127171
Treatment of chronic post-traumatic encephalopathy
Methods of treating chronic post-traumatic encephalopathy (pte) using regenerative approaches is described. In one embodiment, molecules with capability of stimulating endogenous neural stem cells is provided.
04/24/14
20140114070
Compounds that expand hematopoietic stem cells
The present invention relates to compounds and compositions for expanding the number of cd34+ cells for transplantation. The invention further relates to a cell population comprising expanded hematopoietic stem cells (hscs) and its use in autologous or allogeneic transplantation for the treatment of patients with inherited immunodeficient and autoimmune diseases and diverse hematopoietic disorders to reconstitute the hematopoietic cell lineages and immune system defense..
04/24/14
20140112894
Autologous cells on a support matrix for tissue repair
The present invention relates to a method for the effective treatment of tissue defects and for tissue regeneration. The method includes seeding autologous cells on a support matrix and implanting the cell-seeded support matrix into a site of transplantation.
04/24/14
20140112891
Autologous human adult pluripotent very small embryonic-like (hvsel) stem cell regeneration of bone and cartilage
The invention provides methods and compositions for the repair or regeneration of osteochondral tissue. The methods and compositions provide an effective amount of isolated differentiable human very small embryonic like stem cells (hvsels) sufficient for regeneration or repair of an osteochondral tissue.
04/17/14
20140107699
Active loaded fixation devices
The present disclosure relates to methods for producing, including intra-operatively obtaining, a fixation device, and fixation devices produced thereby, containing an autologous cell concentrate from a physiological solution, wherein the cell concentrate is isolated without the need for centrifugation.. .
04/10/14
20140101786
Generation of autologous t-cells in mice
The invention provides an animal model and methods of generating large numbers of diverse, functional, naïve t cells in mice using bone marrow cells from adult donors.. .
04/10/14
20140099383
Topical dermal formulations
An autologous topical formulation containing conditioned medium obtained from culture of autologous fibroblasts has been developed. Unlike other topical formulations, it is autologous since it is derived solely from cells obtained by the person who is to use the formulation.
04/10/14
20140099287
Plasma protein concentrate for cell delivery in regenerative applications
The invention is directed to concentrating autologously-derived plasma, using the concentrated plasma fluid to dilute the patient's cells and applying the combination of concentrated fluid with cells at a site of pathology or mixing the combination of concentrated fluid with cells with a particulate material like a bone void filler prior to placing the mixture at a site of pathology.. .
04/03/14
20140093482
Methods and apparatuses for isolating and preparing stem cells
The present invention relates to a method of preparing a population of stem cells for autologous implantation to a subject. The cells are activated by irradiating the cells with one or more wavelengths of yellow and red and/or green light.
03/27/14
20140087469
System and process for genetic and epigenetic treatment
Transplantation of total or partial organs or tissues from one person to another creates severe immunologic problems and does not obtain a genetic rejuvenation, for example, of half the biological age of the donor's selected tissue. The invention permits, without a return to an embryonic stage, to develop an autologous and genetic rejuvenated (agr) tissue that can be grafted without graft rejection in the donor's body.
03/27/14
20140087002
Autologous lymph node transfer in combination with vegf-c or vegf-d growth factor therapy to treat lymphedema and to improve reconstructive surgery
Materials and methods are provided to improve survival of lymph nodes and integration of lymph nodes into a lymphatic network, following lymph node transplantation. The treatment or prevention of lymphedema is also addressed.
03/13/14
20140071787
Method and apparatus to create autologous clotting serum
A clotting serum production device including a main chamber, an inlet housing, and an outlet port. The main chamber is defined by a first end wall, a second end wall opposite to the first end wall, and a side wall extending between the first end wall and the second end wall.
03/06/14
20140065629
Methods of treating diseases
In one example, the present invention comprises deliberate tumor insult and sequencing of the t cell repertoire before and after the insult in order to detect and sequence the tcr alpha and beta loci of highly expanded t cell clonotypes. In some examples, this information is used in turn to create autologous genetically engineered t cells with tcr sequences that target the individual's tumor..
03/06/14
20140065098
Method to augment immune system in response to disease or injury
In one example, the present invention comprises a deliberate insult or the recognition that an insult has occurred in a patient, which insult induces an immune recognition event. The t cell repertoire is catalogued from samples of the patient's lymphocytes from before and after the insult in order to detect and sequence the tcr alpha and beta loci of highly expanded t cell clonotypes.
03/06/14
20140065096
Cancer therapy by ex vivo activated autologous immune cells
Disclosed are therapeutic methods for ex-vivo activation of immune cells from a cancer patient for the purpose of inducing tumor regression and/or suppressing metastasis and/or tumor recurrence. In one embodiment mononuclear cells of a patient are isolated from peripheral blood and activated by a combination of innate immune system activators together with means allowing for t cell activation..
02/27/14
20140056842
Cellular therapeutic approaches to traumatic brain and spinal cord injury
The described invention provides cellular therapeutic approaches for treating a vascular insufficiency following a traumatic injury to head or spine that results in an injury to brain, spinal cord, or both by administering a therapeutic amount of an isolated, nonexpanded population of autologous mononuclear cells comprising a subpopulation of cd34+ cells, which further contains a subpopulation of potent sdf-1 mobile cd34+/cxcr-4 cells that have cxcr-4-mediated chemotactic activity.. .
02/20/14
20140051662
Treatment of multiple myeloma with masitinib
The present invention relates to the treatment of multiple myeloma, especially for the treatment of those patients with refractory or first relapsed multiple myeloma, and in particular patients with t(4;14) multiple myeloma, comprising administration of a tyrosine kinase inhibitor or a mast cell inhibitor, especially masitinib or a pharmaceutically acceptable salt thereof, administered in association with an additional care in multiple myeloma; for example, autologous stem-cell transplantation, targeted therapies, anti-myeloma agents such as alkylating agents, corticosteroids, or immunomodulatory agents, including bortezomib, lenalidomide, and dexamethasone.. .
02/06/14
20140037615
Materials and methods for designing autologous idiotype vaccines and treatment of b-cell malignancies
The present invention relates to compositions, kits, and methods for preparing an autologous idiotype vaccine, or autologous anti-idiotype vaccine, for treatment of a b-cell malignancy based on the isotype(s) (class(es)) of immunoglobulins expressed by the malignancy; methods for treating b-cell malignancies; and methods for selecting a treatment for a subject having a b-cell malignancy.. .
02/06/14
20140034567
Method and apparatus for producing autologous clotting components
A method and apparatus for obtaining various components of a multi-component material. Generally, a component of a whole blood sample may be concentrated from a patient and re-introduced to the same patient.
01/30/14
20140030806
Adoptive cell therapy with young t cells
The invention provides a method of promoting regression of a cancer in a mammal comprising (i) culturing autologous t cells; (ii) expanding the cultured t cells; (iii) administering to the mammal nonmyeloablative lymphodepleting chemotherapy; and (iv) after administering nonmyeloablative lymphodepleting chemotherapy, administering to the mammal the expanded t cells, wherein the t cells administered to the mammal are about 19 to about 35 days old and have not been screened for specific tumor reactivity, whereupon the regression of the cancer in the mammal is promoted.. .
01/30/14
20140030308
Implants and procedures for promoting autologous stem cell growth
A biologically engineered stent for treating patients suffering from acute myocardial infarction/ischemia. The stent is inserted in a vessel upstream to and proximal the damaged muscle/ischemic area.
01/23/14
20140024888
Method for complex phaloplasty using circumcised foreskin as autograft
Disclosed is a method for complex phalloplasty for widening a penis, using a circumcised foreskin as an autologous graft. In the method, a foreskin cut off by circumcision, conventionally discarded as waste, is implanted as an autograft in phalloplasty, whereby the penis can be widened..
01/23/14
20140023720
Enhanced autologous growth factor production and delivery system
Systems and methods for producing enhanced blood serum with concentrated growth factors and/or prophylactically and therapeutically active proteins. An autologous blood product is obtained from a donor and then incubated into a containment device (sterile container) that includes a source of cells or tissue (for example, autologous, allogeneic, or xenographic tissue, or combinations thereof).
01/16/14
20140018920
Lamina implant and method
A prosthetic implant for restoring lamina after a laminectomy. The implant is generally a lamina-sized construct having a hollow interior.
01/16/14
20140017785
Methods for collecting and processing autografts, processed autografts, kits for collecting and transporting autografts, and tools for preparing autografts
The present invention is directed to methods for collecting and processing autografts, processed autografts, kits for collecting and transporting autografts, and tools for preparing autografts. It is also directed to autologous bone grafts, and methods of preparing them..
01/16/14
20140017783
Non-enzymatic method for isolating human adipose-derived stromal stem cells
A simple method was developed to extract adipose-derived stromal stem cells (ascs) without using enzymatic digestion of the collagen in adipose tissue. The resulting ascs isolated by the simple wash method have lower levels of cd34 expression, a hematopoietic stem cell marker, as compared to ascs isolated using conventional enzymatic digestion using collagenase.
01/09/14
20140010801
Compositions and methods for restoring or rejuvenating stem/progenitor cell function
This invention relates to the use of autologous stem/progenitor cells to restore or rejuvenate adult stem cell function in a mammal, wherein the restoration or rejuvenating extends lifespan and/or improves health of the mammal. In addition, the invention also relates to compositions containing one or more regulatory factors secreted or released from isolated mammalian stem/progenitor cells and use of such compositions to extend lifespan and/or improve health of a mammal.
01/02/14
20140004153
Use of somatic mutations in the extracellular domain of transmembrane proteins in a patient's tumor as immunogens for active humoral immunotherapy of cancer
Methods of identifying tumor-specific mutations that can serve as b cell epitopes for the induction of autologous tumor-specific antibodies are disclosed. In some embodiments, the methods include: identifying a tumor-specific mutation in an expressed gene of a subject having cancer; determining that the mutation is in a region of an open reading frame predicted to encode an extracellular domain of a membrane protein; and identifying a corresponding mutant polypeptide encoded by the expressed gene comprising the tumor-specific mutation.
01/02/14
20140004133
Treatment method for relapsing-remitting multiple sclerosis
Disclosed is a method for treating relapsing-remitting multiple sclerosis in a patient by administering to the patient autologous, ex vivo-expanded cd4+cd25+foxp3+cd127lowt reg cells when the patient is in remission. Also disclosed is a method of inhibiting the activity of autoimmune, autologous cytotoxic t and b cells in a patient suffering from relapsing-remitting multiple sclerosis, comprising administering a therapeutically effective amount of autologous cd4+cd25−foxp3+cd127lowt reg cells to the patient..
12/19/13
20130337017
Fusion proteins of collagen-binding domain and parathyroid hormone
Fusion proteins containing active agonist or antagonist fragments of parathyroid hormone (pth) and parathyroid hormone related peptide (pthrp) coupled to a collagen-binding domain are presented. The fusion proteins can be used to promote bone growth, to promote hair growth, to prevent cancer metastasis to bone, to promote immune reconstitution with a bone marrow stem cell transplant, to promote mobilization of bone marrow stem cells for collection for autologous stem cell transplant, and to treat renal osteodystrophy.


Popular terms: [SEARCH]

Autologous topics: Autologous, Stem Cells, Differentiation, Fibroblast, Cell Therapy, Transplant, Cell Differentiation, Tissue Engineering, Myeloid Leukemia, Gene Expression, Acute Myeloid Leukemia, Complication, Umbilical Cord, Premature Birth, Premature Infant

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Autologous for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Autologous with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.8075

3317

5 - 0 - 71